ALTIMMUNE, INC. (ALT) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | Payments of Dividends |
| Net income · 12 months | -91.76M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $-91.76M | (m) |
| 2026-03-31 | (m) | $-91.08M | (m) |
| 2025-12-31 | (m) | $-88.09M | (m) |
| 2025-09-30 | (m) | $-83.92M | (m) |
| 2025-06-30 | (m) | $-87.75M | (m) |
| 2025-03-31 | (m) | $-90.24M | (m) |
| 2024-12-31 | (m) | $-95.06M | (m) |
| 2024-09-30 | (m) | $-103.52M | (m) |
| 2024-06-30 | (m) | $-101.35M | (m) |
| 2024-03-31 | (m) | $-92.77M | (m) |
| 2023-12-31 | (m) | $-88.45M | (m) |
| 2023-09-30 | (m) | $-78.47M | (m) |
| 2023-06-30 | (m) | $-81.31M | (m) |
| 2023-03-31 | (m) | $-85.36M | (m) |
| 2022-12-31 | (m) | $-84.71M | (m) |
| 2022-09-30 | (m) | $-86.94M | (m) |
| 2022-06-30 | (m) | $-96.94M | (m) |
| 2022-03-31 | (m) | $-101.66M | (m) |
| 2021-12-31 | (m) | $-97.09M | (m) |
| 2021-09-30 | (m) | $-83.82M | (m) |
| 2021-06-30 | (m) | $-68.08M | (m) |
| 2021-03-31 | (m) | $-60.02M | (m) |
| 2020-12-31 | (m) | $-49.04M | (m) |
| 2020-09-30 | (m) | $-42.52M | (m) |
| 2020-06-30 | (m) | $-35.69M | (m) |
| 2020-03-31 | (m) | $-22.31M | (m) |
| 2019-12-31 | (m) | $-20.52M | (m) |
| 2019-09-30 | (m) | $-40.93M | (m) |
| 2019-06-30 | (m) | $-32.34M | (m) |
| 2019-03-31 | (m) | $-38.09M | (m) |
| 2018-12-31 | (m) | $-39.17M | (m) |
| 2018-09-30 | (m) | $-23.49M | (m) |
| 2018-06-30 | (m) | $-51.05M | (m) |
| 2018-03-31 | (m) | $-45.02M | (m) |
| 2017-12-31 | (m) | $-46.43M | (m) |
| 2017-09-30 | (m) | $164.28M | (m) |
| 2017-06-30 | (m) | $189.39M | (m) |
| 2017-03-31 | (m) | $192.88M | (m) |
| 2016-12-31 | (m) | $193.85M | (m) |
| 2016-09-30 | (m) | $114.81M | (m) |
| 2016-06-30 | (m) | $4.25M | (m) |
| 2016-03-31 | (m) | $-6.13M | (m) |
| 2015-12-31 | (m) | $-3.44M | (m) |
| 2015-09-30 | (m) | $-4.83M | (m) |
| 2015-06-30 | (m) | $-8.14M | (m) |
| 2015-03-31 | (m) | $-6.23M | (m) |
| 2014-12-31 | (m) | $-9.96M | (m) |
| 2014-09-30 | (m) | $-11.75M | (m) |
| 2014-06-30 | (m) | $-11.07M | (m) |
| 2014-03-31 | (m) | $-11.87M | (m) |
| 2013-12-31 | (m) | $-11.72M | (m) |
| 2013-09-30 | (m) | $-8.56M | (m) |
| 2013-06-30 | (m) | $-4.83M | (m) |
| 2013-03-31 | (m) | $-4.35M | (m) |
| 2012-12-31 | (m) | $-4.92M | (m) |
| 2012-09-30 | (m) | $-2.90M | (m) |
| 2012-06-30 | (m) | $-2.72M | (m) |
| 2012-03-31 | (m) | $-4.40M | (m) |
| 2011-12-31 | (m) | $-3.80M | (m) |
| 2011-09-30 | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) |
| 2010-12-31 | (m) | $-34.85M | (m) |
| 2010-09-30 | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |